These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31439038)

  • 1. Clinical exome sequencing identifies two novel mutations of the SCN1A and SCN2A genes in Moroccan patients with epilepsy: a case series.
    Sahli M; Zrhidri A; Elaloui SC; Smaili W; Lyahyai J; Oudghiri FZ; Sefiani A
    J Med Case Rep; 2019 Aug; 13(1):266. PubMed ID: 31439038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between SCN1A and SCN2A mutations and clinical/EEG features in Chinese patients from epilepsy or severe seizures.
    Kong Y; Yan K; Hu L; Wang M; Dong X; Lu Y; Wu B; Wang H; Yang L; Zhou W
    Clin Chim Acta; 2018 Aug; 483():14-19. PubMed ID: 29649454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missense mutations in sodium channel SCN1A and SCN2A predispose children to encephalopathy with severe febrile seizures.
    Saitoh M; Ishii A; Ihara Y; Hoshino A; Terashima H; Kubota M; Kikuchi K; Yamanaka G; Amemiya K; Hirose S; Mizuguchi M
    Epilepsy Res; 2015 Nov; 117():1-6. PubMed ID: 26311622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel and de novo variant in the SCN1A gene confirms Dravet syndrome in Moroccan child: a case report.
    El Mouhi H; Amllal N; Abbassi M; Nedbour A; Jalte M; Lyahyai J; Chafai Elalaoui S; Bouguenouch L; Chaouki S
    Mol Biol Rep; 2024 Jan; 51(1):233. PubMed ID: 38282049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy.
    Wang JW; Shi XY; Kurahashi H; Hwang SK; Ishii A; Higurashi N; Kaneko S; Hirose S;
    Epilepsy Res; 2012 Dec; 102(3):195-200. PubMed ID: 23195492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
    Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
    Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.
    Hawkins NA; Martin MS; Frankel WN; Kearney JA; Escayg A
    Neurobiol Dis; 2011 Mar; 41(3):655-60. PubMed ID: 21156207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
    Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
    Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
    Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
    Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The finding of a new heterozygous mutation site of the SCN2A gene in a monozygotic twin family carrying and exhibiting genetic epilepsy with febrile seizures plus (GEFS+) using targeted next-generation sequencing.
    Liu XW; Li W; Han T; Wei K; Qiao S; Su L; Chi Z
    Clin Neurol Neurosurg; 2018 Jun; 169():86-91. PubMed ID: 29635106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular analysis of epilepsy-related genes in patients with Dravet syndrome.
    Jiang T; Shen Y; Chen H; Yuan Z; Mao S; Gao F
    Medicine (Baltimore); 2018 Dec; 97(50):e13565. PubMed ID: 30558019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the best candidates for next-generation sequencing-based gene panel for evaluation of early-onset epilepsy.
    Lee J; Lee C; Ki CS; Lee J
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1376. PubMed ID: 32613771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations.
    Bonanni P; Malcarne M; Moro F; Veggiotti P; Buti D; Ferrari AR; Parrini E; Mei D; Volzone A; Zara F; Heron SE; Bordo L; Marini C; Guerrini R
    Epilepsia; 2004 Feb; 45(2):149-58. PubMed ID: 14738422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical exome sequencing as the first-tier test for diagnosing developmental disorders covering both CNV and SNV: a Chinese cohort.
    Dong X; Liu B; Yang L; Wang H; Wu B; Liu R; Chen H; Chen X; Yu S; Chen B; Wang S; Xu X; Zhou W; Lu Y
    J Med Genet; 2020 Aug; 57(8):558-566. PubMed ID: 32005694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies.
    Zhou P; He N; Zhang JW; Lin ZJ; Wang J; Yan LM; Meng H; Tang B; Li BM; Liu XR; Shi YW; Zhai QX; Yi YH; Liao WP
    Genes Brain Behav; 2018 Nov; 17(8):e12456. PubMed ID: 29314583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of 13 Novel Genetic Variants in Genes Associated with Epilepsy: Implications for Targeted Therapeutic Strategies.
    Andjelkovic M; Klaassen K; Skakic A; Marjanovic I; Kravljanac R; Djordjevic M; Vucetic Tadic B; Kecman B; Pavlovic S; Stojiljkovic M
    Mol Diagn Ther; 2024 Sep; 28(5):645-663. PubMed ID: 39003674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy.
    Lu Y; Su Q; Li M; Dayimu A; Dai X; Wang Z; Che F; Xue F
    Biomed Res Int; 2020; 2020():8096235. PubMed ID: 32185219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-Exome Sequencing Implicates
    Maksemous N; Smith RA; Sutherland HG; Sampaio H; Griffiths LR
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.